Month: February 2020
-
Foundation Supports ALS Inflammation Treatments
A foundation is funding a biotechnology company’s research on therapies to block proteins encouraging neuron inflammation in people with amyotrophic lateral sclerosis, or ALS.
-
Waste Plastic-to-Energy System Unveiled
A company developing waste-to-energy conversion systems revealed a version of its product that converts waste plastic to heat and electric power.
-
Infographic – U.S. Having Bad Flu Season
According to data from the Centers for Disease Control and Prevention, the infection rate for this year’s seasonal influenza is among the highest in the past five years.
-
Infant Jumpsuit Captures Objective Movement Data
A one-piece garment fitted with sensors is shown to capture data about an infant’s movements for analysis by algorithms to reveal possible developmental problems.
-
Wireless Smart Bandage Designed for Chronic Wounds
A university lab developed a wirelessly-controlled programmable bandage that in tests with lab mice results in more diabetic wound closure than topical medicines.
-
Controlling Your Business’s Narrative
You want to control your narrative, because when people hear your story, you want them to take a positive message from it.
-
Enrollment Completed in Aging Frailty Stem Cell Trial
A company developing stem cell treatments to counter frailty in older people finished enlisting participants in a clinical trial testing its therapies.
-
Time Saving Techniques for Your Business
A lot of entrepreneurs struggle with time management, so there are a few solutions that might help you.
-
Engineered Bacteria Deliver Cancer Immunotherapy
13 Feb. 2020. A biomedical engineering team designed probiotic bacteria, which in lab mice are shown to deliver and enhance cancer immunotherapy drugs. Researchers at Columbia University in New York describe their engineered bacteria and findings in yesterday’s issue of the journal Science Translational Medicine (paid subscription required). Treatments that invoke the immune system to…
-
Synthetic Cell Matrix Devised for Cancer Drug Testing
A bioengineering lab is creating synthetic cell scaffolds that simulate tumor cells and tissue, offering a more reliable way of testing new cancer drugs.